Consider Stopping Overactive Bladder Meds During Hospitalization

You'll hear controversy surrounding overactive bladder meds and fall risk.

Many hospitals use immediate-release oral antimuscarinics, such as oxybutynin (Ditropan, etc) or tolterodine (Detrol, etc), as therapeutic interchanges when patients are taking overactive bladder meds at home. It's hoped that fewer trips to the bathroom will lead to fewer falls.

But help put the efficacy and safety of overactive bladder meds into perspective. For example, these meds decrease bathroom trips in women from about 11 per day to 9 or 10.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote